Feedback / Questions
berubicin (RTA 744) - CNS Pharma, WPD Pharma
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-call-to-discuss-fda-ind-approval-and-phase-2-trial-for-berubicin-301195577.html
Dec 17, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next